How to buy biotech stocks and get your hands on some of the best biotech stocks
The best biotech companies have some of those ingredients, too.
And that’s one reason why the world’s biggest drugmaker, Bayer AG, is the largest beneficiary of biotech stocks this year, according to the data provider S&P Dow Jones Indices.
Bayer, a global drugmaker that makes the popular painkiller Vioxx and the antibiotic Prozac, has been the top beneficiary of the biotech sector since the start of the year, with a market capitalization of $6.4 trillion.
Beside Bayer, pharma giant Eli Lilly & Co., the second-biggest pharma company, is another biotech company to be on the shortlist for the top spot.
The company, which makes the antiviral drug Daraprim, has more than tripled in value since the beginning of the quarter.
The top biotech stocks for 2016:Alphabet Inc, the Google-owned company that has dominated the field with its search engine, has the second largest market cap in the sector with a $8.8 trillion market cap, after biotech giants Eli Lilly and Pfizer.
Other biotech stocks that are on the list include United Therapeutics Inc, which is developing the drug Sustiva, and Bristol-Myers Squibb, which has been selling its own drugs.
Bristol-Myer, which recently announced a $2.7 billion deal to buy AstraZeneca, is also in the top 10 of the top-performing biotech stocks, with an average return of 2.3%.
The company is the world leader in the development and delivery of cancer drugs.
Forbes recently ranked the 10 most lucrative biotech stocks.
In its annual list, Forbes says the sector has grown at a CAGR of 8.3% in 2016 and is expected to grow by about 6.5% in 2017.